Evidence map›Paper›PMID 27871173›Full record

ArticleMolecules and cells2016

STAT3 Potentiates SIAH-1 Mediated Proteasomal Degradation of β-Catenin in Human Embryonic Kidney Cells.

Minkyung Shin, Eun Hee Yi, Byung-Hak Kim, Jae-Cheon Shin, Jung Youl Park, Chung-Hyun Cho, Jong-Wan Park, Kang-Yell Choi, Sang-Kyu Ye

Open access · diamondAbstract read
In one paragraph

Article in Molecules and cells, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Minkyung ShinDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
Eun Hee YiDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
Byung-Hak KimDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
Jae-Cheon ShinPohang Center for Evaluation of Biomaterials, Pohang 37673, Korea.
Jung Youl ParkIndustry-Academic Cooperation Foundation, Hanbat National University, Daejeon 34158, Korea.
Chung-Hyun ChoDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
Jong-Wan ParkDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
Kang-Yell ChoiDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 09722, Korea.
Sang-Kyu YeDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
Seoul National University · KRHanbat National University · KRPohang TechnoPark (South Korea) · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The β-catenin functions as an adhesion molecule and a component of the Wnt signaling pathway. In the absence of the Wnt ligand, β-catenin is constantly phosphorylated, which designates it for degradation by the APC complex. This process is one of the key regulatory mechanisms of β-catenin. The level of β-catenin is also controlled by the E3 ubiquitin protein ligase SIAH-1 via a phosphorylation-independent degradation pathway. Similar to β-catenin, STAT3 is responsible for various cellular processes, such as survival, proliferation, and differentiation. However, little is known about how these molecules work together to regulate diverse cellular processes. In this study, we investigated the regulatory relationship between STAT3 and β-catenin in HEK293T cells. To our knowledge, this is the first study to report that β-catenin-TCF-4 transcriptional activity was suppressed by phosphorylated STAT3; furthermore, STAT3 inactivation abolished this effect and elevated activated β-catenin levels. STAT3 also showed a strong interaction with SIAH-1, a regulator of active β-catenin via degradation, which stabilized SIAH-1 and increased its interaction with β-catenin. These results suggest that activated STAT3 regulates active β-catenin protein levels via stabilization of SIAH-1 and the subsequent ubiquitin-dependent proteasomal degradation of β-catenin in HEK293T cells.

Indexed as

Basic Helix-Loop-Helix Leucine Zipper Transcription Factorsbeta CateninHEK293 CellsHumansKidneyNuclear ProteinsPhosphorylationProteasome Endopeptidase ComplexSeven in Absentia ProteinsSTAT3 Transcription FactorTranscription Factor 4Transcription FactorsTranscription, GeneticTransfectionUbiquitin-Protein LigasesBasic Helix-Loop-Helix Leucine Zipper Transcription Factorsbeta CateninCTNNB1 protein, humanNuclear ProteinsProteasome Endopeptidase ComplexSeven in Absentia ProteinsSTAT3 protein, humanSTAT3 Transcription FactorTCF4 protein, humanTranscription Factor 4Transcription FactorsUbiquitin-Protein Ligasesproteasomal degradationSIAH-1STAT3β-catenin

Identifiers

PMID27871173
PMCPMC5125938
OpenAlexW2560651798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.